Alleviant ALLAY-HF Study

Recruiting

NAAges 40+InterventionalTreatment

Alleviant Medical, Inc.

~700 participants

Updated 2026-08-14 on ClinicalTrials.gov

What's tested:Alleviant ALV1 SystemSham-Control

At a glance

Recruiting sites

75 of 93 listed sites are recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Composite Primary Endpoint

Measured over 12-month

Heart Failure

NCT05685303

This study runs at 93 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

4th Military Hospital
Wroclaw, Polandno site contact published
Recruiting
Advent Health Orlando
Orlando, Floridano site contact published
Recruiting
Ascension Sacred Heart
Pensacola, Floridano site contact published
Recruiting
Atlanta VA Health Care System
Decatur, Georgiano site contact published
Recruiting
Austin Heart
Austin, Texasno site contact published
Recruiting
Austin Hospital
Heidelberg, Victoria, Australiano site contact published
Recruiting
AZ Sint Jan Brugge
Bruges, Belgiumno site contact published
Recruiting
Barcelona Hospital del Mar
Barcelona, Spainno site contact published
Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Jennifer Olson

Opens a ready-to-send draft in your own email app — review before sending.

Composite Primary Endpoint12-month
The primary endpoint is a composite of mortality, heart failure events and quality of life based on Kansas City Cardiomyopathy Questionnaire (KCCQ) calculated at 12 months. KCCQ responses are provided along a rating scale from 0-100 with a higher score indicating better health.